JAK inhibitors and other oral immunology drugs on AARP Medicare Rx Saver from UHC (S5921-376)
Rinvoq, Xeljanz, Olumiant and Otezla, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), California
- Premium
- $109.40/month
- Deductible
- $615.00
1 of 5 JAK inhibitors is covered on this plan. It requires prior authorization.
4 aren't on the formulary, including Rinvoq and Xeljanz.
- from $230.29Tier 5
Not on the formulary
Rinvoq, Xeljanz, Olumiant, Sotyktu
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.